biopharmaceutical - Health Technology Insights

April 14, 2025
HealthTech Media Room
HealthTech News, Pharmaceuticals, Treatments

Soleno Therapeutics Announces VYKAT(TM) XR Launch

First prescriptions delivered to individuals with PWS Soleno Therapeutics, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced the U.S. commercial availability of VYKAT...

April 1, 2025
HealthTech Media Room
AI in Healthcare, Business, Clinical Trials, Diagnostics and Devices, Genomics and Precision Medicine, HealthTech News

Semaphore Solutions Secures Investment to Grow Labbit AI Platform

Semaphore Solutions, a leader in laboratory informatics solutions, announces a new investment from Cypress Ridge Capital (“CRC”) to further accelerate the growth of its flagship platform, Labbit. The growth...

March 10, 2025
HealthTech Media Room
HealthTech News, Medical Facilities, Medical Technology, Surgical & Advanced Therapies, Treatments

VIVUS Launches QSYMIA in the United Arab Emirates

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, announced the market...

Harbour BioMed and Insilico Medicine Collaborate to Antibody Discovery

February 20, 2025
HealthTech Media Room
AI in Healthcare, Health Services, HealthTech News, immunity

Harbour Biomed and Insilico Medicine Collaborate to Advance AI-Driven Antibody Discovery

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine, a clinical stage generative...

February 13, 2025
HealthTech Media Room
Biotechnology, HealthTech News, Pharmaceuticals, Pharmacogenomics

Antengene Announces XPOVIO Approval for Public Health Insurance in Taiwan

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, announced that XPOVIO (selinexor) in combination with bortezomib and...

January 8, 2025
HealthTech Media Room
AI in Healthcare, Analytics & AI, Health, HealthTech News

Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform

Coeptis Therapeutics Holdings, a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, is excited to announce the initial rollout of its recently introduced...

Soleno Therapeutics Announces VYKAT(TM) XR Launch

Semaphore Solutions Secures Investment to Grow Labbit AI Platform

VIVUS Launches QSYMIA in the United Arab Emirates

Harbour Biomed and Insilico Medicine Collaborate to Advance AI-Driven Antibody Discovery

Antengene Announces XPOVIO Approval for Public Health Insurance in Taiwan

Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform

Fuel up with free Health Tech Insights

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands